I

    IDEXX Laboratories Inc (IDXX)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $556.69
    +1.70 (+0.31%)

    Market Cap: $43.72B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    98%(39/40)
    Avg Surprise
    +10.10%
    Streak
    16 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$3.71
    Range$3.37 - $3.91
    12 analysts
    EPS Revisions
    2
    0
    7d
    2
    6
    30d
    EPS Estimate Drift
    90d ago$3.78+2.0%
    60d ago$3.78+2.0%
    30d ago$3.78+2.0%
    7d ago$3.71+0.0%
    Current$3.71
    Revenue Consensus
    $1.2B
    Range$1.2B - $1.2B
    11 analysts
    Dec 31, 2026
    EPS Consensus$3.78
    Range$3.41 - $4.12
    13 analysts
    Revenue Consensus
    $1.2B
    Range$1.2B - $1.2B
    13 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$3.78---
    Sep 26EST
    		-$3.71---
    Jun 26
    		$4.27$3.95+8.10%Beat+17.6%
    Mar 26
    		$3.47$3.41+1.76%Beat+17.2%
    Dec 25
    		$3.08$2.94+4.76%Beat+17.6%
    Sep 25
    		$3.40$3.15+7.94%Beat+21.4%
    Jun 25
    		$3.63$3.30+10.00%Beat+20.2%
    Mar 25
    		$2.96$2.84+4.23%Beat+5.3%
    Dec 24
    		$2.62$2.40+9.17%Beat+12.9%
    Sep 24
    		$2.80$2.69+4.09%Beat+10.7%
    Jun 24
    		$3.02$2.87+5.23%Beat+13.1%
    Mar 24
    		$2.81$2.67+5.24%Beat+10.2%
    Dec 23
    		$2.32$2.12+9.43%Beat+13.2%
    Sep 23
    		$2.53$2.37+6.75%Beat+17.7%
    Jun 23
    		$2.67$2.47+8.10%Beat+71.2%
    Mar 23
    		$2.55$2.43+4.94%Beat+12.3%
    Dec 22
    		$2.05$1.92+6.77%Beat+8.5%
    Sep 22
    		$2.15$2.04+5.39%Beat+5.9%
    Jun 22
    		$1.56$1.63-4.29%Miss-33.3%
    Mar 22
    		$2.27$2.25+0.89%Beat-3.4%
    Dec 21
    		$1.89$1.72+9.88%Beat+7.4%
    Sep 21
    		$2.03$1.91+6.28%Beat+20.1%
    Jun 21
    		$2.34$2.04+14.71%Beat+36.0%
    Mar 21
    		$2.35$1.72+36.63%Beat+82.2%
    Dec 20
    		$1.76$1.39+26.62%Beat+69.2%
    Sep 20
    		$1.69$1.44+17.36%Beat+36.3%
    Jun 20
    		$1.72$1.17+47.01%Beat+20.3%
    Mar 20
    		$1.29$1.20+7.50%Beat+10.3%
    Dec 19
    		$1.04$0.90+15.56%Beat+6.1%
    Sep 19
    		$1.24$1.14+8.77%Beat+18.1%
    Jun 19
    		$1.43$1.37+4.38%Beat+16.3%
    Mar 19
    		$1.17$1.06+10.38%Beat+15.8%
    Dec 18
    		$0.98$0.91+7.69%Beat+27.3%
    Sep 18
    		$1.05$0.97+8.25%Beat+32.9%
    Jun 18
    		$1.23$1.17+5.13%Beat+29.5%
    Mar 18
    		$1.01$0.92+9.78%Beat+31.2%
    Dec 17
    		$0.77$0.73+5.48%Beat+32.8%
    Sep 17
    		$0.79$0.74+6.76%Beat+27.4%
    Jun 17
    		$0.95$0.85+11.76%Beat-
    Mar 17
    		$0.77$0.60+28.33%Beat-
    Dec 16
    		$0.58$0.51+13.73%Beat-
    Sep 16
    		$0.62$0.60+3.33%Beat-

    Key Metrics

    Valuation
    P/E Ratio39.15EV/EBITDA27.12x
    Price/FCF35.04xFCF Yield2.85%
    Profitability
    Profit Margin25.00%Operating Margin35.00%
    ROE74.20%ROIC45.21%
    Financial Health
    Debt/Equity0.60xInterest Coverage38.60x
    Current Ratio1.17xQuick Ratio0.87x
    Trading Statistics
    Beta1.54Avg Volume609.53K
    52-Week High$769.9852-Week Low$518.55

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$553.80
    SMA 20$565.23
    SMA 50$558.99
    SMA 200$610.27
    EMA 10$555.38
    EMA 20$558.66
    EMA 50$561.07
    EMA 200$580.66

    MACD

    Line: -3.27Signal: -1.99Hist: -1.28

    ADX

    ADX: 9.8+DI: 22.0-DI: 22.7

    Aroon & PSAR

    Aroon Up24.0
    Aroon Down60.0
    PSAR$594.35

    Bollinger Bands

    Upper Band$599.42
    Lower Band$531.04
    %B Position1210%(Upper)
    Band Width0.38

    RSI (14-Day)

    Neutral
    48.6

    Momentum Oscillators

    Stoch %K26.2
    Stoch %D21.6
    Williams %R-59.8
    ROC (10d)1.9%
    Momentum10.60
    CCI (20d)-53.6
    MFI (14d)41.9

    Volatility Measures

    ATR (14d)$16.40(2.9%)
    StdDev (20d)17.09
    Hist Vol28.5%(Moderate)

    Volume Flow

    VWAP$553.84
    OBV15.6M
    AD Line8.0M
    CMF (20d)-0.219

    Volume Metrics

    Avg Vol (20d)579.6K
    Vol Ratio1.1x
    VWMA (20d)$568.64

    Pivot Points

    R3$569.37
    R2$562.69
    R1$558.84
    Pivot Point$552.16
    S1$548.31
    S2$541.63
    S3$537.78

    Advanced Oscillators

    TSI-5.29
    Ultimate Osc55.9
    KST-11.73

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$1.22B$1.14B$1.09B$1.11B$1.11B$998.43M$954.29M$975.54M$1.00B$964.10M$901.60M$915.53M
    Cost of Revenue$437.50M$418.08M$432.46M$421.88M$414.73M$375.05M$383.63M$379.50M$384.42M$371.02M$375.43M$367.55M
    Gross Profit$779.09M$722.74M$658.11M$683.35M$694.73M$623.38M$570.66M$596.04M$619.16M$593.07M$526.17M$547.98M
    Operating Expenses$353.52M$360.15M$342.51M$328.51M$321.69M$306.85M$308.97M$292.15M$355.36M$294.11M$280.87M$272.70M
    R&D$65.43M$65.79M$66.83M$63.41M$61.90M$59.06M$57.73M$53.98M$55.45M$52.63M$51.81M$47.97M
    SG&A$116.81M$119.11M$108.62M$105.94M$98.68M$91.56M$101.14M$91.89M$157.24M$92.02M$87.02M$89.03M
    Operating Income$425.57M$362.59M$315.61M$354.85M$373.05M$316.53M$261.69M$303.89M$263.80M$298.96M$245.30M$275.28M
    Interest Income$1.84M$597,000$587,000$580,000$627,000$1.22M$2.20M$2.71M$3.35M$4.43M$3.63M$1.25M
    Interest Expense$10.18M$7.74M$9.21M$10.65M$11.32M$7.67M$7.50M$7.70M$8.10M$7.91M$9.27M$8.65M
    Income Before Tax$417.22M$355.44M$306.98M$344.77M$362.35M$310.08M$256.39M$298.91M$259.06M$295.48M$239.67M$267.89M
    Income Tax Expense$78.81M$77.00M$58.79M$70.16M$68.36M$67.41M$40.24M$66.07M$55.76M$59.90M$45.15M$55.66M
    Net Income$338.41M$278.45M$248.19M$274.61M$293.99M$242.68M$216.15M$232.84M$203.30M$235.58M$194.52M$212.23M
    EBITDA$466.62M$400.27M$354.33M$391.47M$408.82M$350.60M$295.39M$338.02M$295.99M$328.86M$275.04M$304.27M
    EBIT$425.57M$362.59M$315.61M$354.85M$373.05M$316.53M$261.69M$303.89M$263.80M$298.96M$245.30M$275.28M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about IDXX

    Government Contracts

    Gov Obligations (TTM)
    $2.07M
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    22.3%
    Active Awards
    96
    New Awards (TTM)
    51
    Avg Remaining Term
    8.4 mo

    Top agency: Department of Health and Human Services at 67.2% of trailing twelve month obligations across 5 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    75N98026F00001Department of Health and Human ServicesNational Institutes of Health$594443Jul 1, 2026
    75N98026F00002Department of Health and Human ServicesNational Institutes of Health$390000Apr 10, 2026
    75N98026F00001Department of Health and Human ServicesNational Institutes of Health$230000Oct 1, 2025
    75N98025F00010Department of Health and Human ServicesNational Institutes of Health$185000May 1, 2025
    12639526F0321Department of AgricultureAnimal and Plant Health Inspection Service$153367Mar 17, 2026
    1232SA25P0452Department of AgricultureAgricultural Research Service$110800Sep 22, 2025
    N0010426PBH04Department of DefenseDepartment of the Navy$102840Jan 28, 2026
    12639526F0497Department of AgricultureAnimal and Plant Health Inspection Service$92883May 5, 2026
    W81K0025PA184Department of DefenseDepartment of the Army$56515Sep 4, 2025
    12639525F0957Department of AgricultureAnimal and Plant Health Inspection Service$27700Aug 22, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Resilient IDEXX Laboratories stock trades above $550 as growth outlook stays strong

    IDEXX Laboratories stock is trading above $550, driven by a strong growth outlook, including an anticipated 13.2% year-over-year earnings growth for the current fiscal year, and positive analyst sentiment. Six analysts have raised their earnings estimates for fiscal 2026, pushing the consensus EPS to $14.81. Despite a premium valuation, analysts maintain a "Moderate Buy" rating with an average price target of $747.00, indicating significant potential upside.

    AD HOC NEWS•8/31/26•
    Bullish

    IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference

    IDEXX Laboratories, Inc. (Nasdaq: IDXX) announced that its President and CEO, Mike Erickson, and Executive Vice President and CFO, Andrew Emerson, will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference. The event is scheduled for Monday, September 14, 2026, from 10:45 am – 11:20 am ET, and a live audio webcast will be available on the IDEXX investor relations website.

    Yahoo Finance•8/31/26•
    Neutral

    IDEXX Laboratories Inc. stock outperforms competitors on strong trading day

    IDEXX Laboratories Inc. (IDXX) shares rallied 1.82% to $554.99 on Friday, outperforming the broader market as both the S&P 500 and Dow Jones Industrial Average experienced declines. The company's stock closed 27.92% below its 52-week high. This performance occurred despite a generally tough trading session for the stock market.

    MarketWatch•8/29/26•
    Bullish

    IDEXX Laboratories Inc. (IDXX) Key Financial Ratios – Valuation, Profitability & More

    This article provides a detailed analysis of IDEXX Laboratories Inc. (IDXX) through its key financial ratios, covering valuation, profitability, growth, solvency, and operating efficiency. It presents TTM data alongside yearly figures and compares IDEXX's performance against peer medians across various metrics like ROE, EBIT Margin, Revenue Growth, and Debt to Equity. The analysis highlights IDEXX's strengths in profitability and growth compared to its peers.

    Value Research•8/28/26•
    Bullish

    IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day

    IDEXX Laboratories Inc. (IDXX) stock decreased by 1.51% to $545.08, despite a positive trading day for the broader market, with the S&P 500 and Dow Jones Industrial Average both rising. The company's stock closed 29.21% below its 52-week high.

    MarketWatch•8/27/26•
    Neutral

    Frequently Asked Questions About IDXX

    Does IDXX pay dividends?
    IDEXX Laboratories Inc (IDXX) does not currently pay a regular dividend.
    What is IDXX's P/E ratio?
    IDEXX Laboratories Inc has a price-to-earnings (P/E) ratio of 39.15.
    What is IDXX's market cap?
    IDEXX Laboratories Inc (IDXX) has a market capitalization of $43.72B with a current stock price of $556.69.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In